NCT03541265View on ClinicalTrials.gov

Liposomal Bupivacaine in Total Knee Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 1, 2016

Primary Completion Date

June 1, 2017

Study Completion Date

March 1, 2018

Conditions
Knee OsteoarthritisAnesthesia, Local
Interventions
DRUG

Exparel

long-acting Bupivacaine extended release liposome compound

PROCEDURE

Adductor block protocol

Adductor block using Exparel

PROCEDURE

peri-articular injection protocol

peri-articular injection using Exparel

All Listed Sponsors
lead

Bronx-Lebanon Hospital Center Health Care System

OTHER

NCT03541265 - Liposomal Bupivacaine in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter